Clinical Trial Update: Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 1/2 trial investigating Holmium-166 DOTMP followed by peripheral stem cell transplantation in patients with metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Holmium-166 DOTMP (holmium-166 DOTMP)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Metastatic Cancer, Sarcoma | Phase 1, Phase 2 | Status: COMPLETED